TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36458325

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg daily with amoxicillin 1000 mg, furazolidone 100 mg, and colloidal bismuth 200 mg each given twice a day for 10 days (V10)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg daily with amoxicillin 1000 mg, furazolidone 100 mg, and colloidal bismuth 200 mg each given twice a day for 14 days (V14)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Esomeprazole 20 mg with amoxicillin 1000 mg, furazolidone 100 mg, and colloidal bismuth 200 mg each given twice a day for 14 days (E14)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg daily (V10)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg daily (V14)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Esomeprazole 20 mg (E14)
Number of subjects: 234
Study: 32516805

Group type: EXPERIMENTAL
Intervention: GRACE 2.0 score for type 1 myocardial infarction
Number of subjects: 70271

Group type: EXPERIMENTAL
Intervention: GRACE 2.0 score for type 2 myocardial infarction
Number of subjects: 70271
Study: 32475048

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 42
Study: 35986979

Group type: EXPERIMENTAL
Intervention: Ultrasound-first clinical decision support (CDS) tool
Number of subjects: 254

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 254
Study: 34338146

Group type: EXPERIMENTAL
Intervention: miR‐101‐3p mimic group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CUL4B siRNA group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CUL4B siRNA plus miR‐101‐3p inhibitor group
Number of subjects: 75

Group type: COMPARATOR
Intervention: siRNA negative control (NC) group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Blank group
Number of subjects: 75
Study: 34817421

Group type: EXPERIMENTAL
Intervention: Noradrenaline 5 μg min-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenylephrine 100 μg min-1
Number of subjects: 0
Study: 34453521

Group type: EXPERIMENTAL
Intervention: World Health Organization class III obesity (BMI > 40 kg/m2)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Less severe obesity (BMI 35 ± 5 kg/m2) during dobutamine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Surgical weight loss (n = 37)
Number of subjects: 103
Study: 34237154

Group type: EXPERIMENTAL
Intervention: TACE plus lenvatinib (12 mg orally once daily for body weight ≥60 kg or 8 mg for body weight <60 kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: TACE plus sorafenib (400 mg orally twice daily in 28-day cycles)
Number of subjects: 64
Study: 32125668

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon autograft (QTB)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Semitendinosus-gracilis autograft (StG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy controls (CON)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both QTB and StG
Number of subjects: 100
Study: 35597733

Group type: EXPERIMENTAL
Intervention: taVNS
Number of subjects: 8

Group type: COMPARATOR
Intervention: CS
Number of subjects: 8
Study: 35666260

Group type: EXPERIMENTAL
Intervention: Therapist guided game‐based intervention program (TGGIP)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Self‐oriented, nonsupervised program (GIP)
Number of subjects: 138
Study: 34443994

Group type: EXPERIMENTAL
Intervention: Live music therapy applied during sleep
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Live music therapy applied in awake state
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Live music therapy (general)
Number of subjects: 20
Study: 32636279

Group type: EXPERIMENTAL
Intervention: 0 PEEP baseline SpO2
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 0 PEEP + 0.20
Number of subjects: 38
Study: 36194395

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32668005

Group type: EXPERIMENTAL
Intervention: ICT-enhanced integrated care model (SPEC)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 482
Study: 32401099

Group type: EXPERIMENTAL
Intervention: FearFighter ICBT program (n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (n = 32)
Number of subjects: 64
Study: 33843267

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 104
Study: 33051228

Group type: EXPERIMENTAL
Intervention: Clindamycin 300 mg ×2 daily for 7 days followed by vaginal Lactobacillus crispatus CTV‐05 until clinical pregnancy scan week 7‐9
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Clindamycin and placebo L. crispatus CTV‐05
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo/placebo
Number of subjects: 333
Study: 34633260

Group type: EXPERIMENTAL
Intervention: S086 (single ascending doses: 60-1080 mg)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: S086 (multiple ascending doses: 180-720 mg)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 33410497

Group type: EXPERIMENTAL
Intervention: Indicated prevention strategy (IPS) in RCT I
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Indicated prevention strategy (IPS) in RCT II
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group in RCT I
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group in RCT II
Number of subjects: 402
Study: 33511399

Group type: EXPERIMENTAL
Intervention: Flannel drag fabric
Number of subjects: 0

Group type: COMPARATOR
Intervention: Canvas drag fabric
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corduroy drag fabric
Number of subjects: 0
Study: 36214066

Group type: EXPERIMENTAL
Intervention: ANTICIPATE models
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: FIB4+ model (using FIB-4 plus serum albumin)
Number of subjects: 222
Study: 33952540

Group type: EXPERIMENTAL
Intervention: Video-based consultation involving patient, general practitioner (GP), and oncologist
Number of subjects: 9
Study: 33349906

Group type: EXPERIMENTAL
Intervention: Diabetes SPECIAL elective
Number of subjects: 10
Study: 33167705

Group type: EXPERIMENTAL
Intervention: 1-month dual antiplatelet therapy (DAPT) followed by single antiplatelet therapy
Number of subjects: 1506

Group type: COMPARATOR
Intervention: Single antiplatelet therapy
Number of subjects: 1506
Study: 33453399

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 1930728

Group type: COMPARATOR
Intervention: No PPI use
Number of subjects: 1930728
Study: 33812945

Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left dlPFC (1 mA for 20 min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left dlPFC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition (sham tDCS)
Number of subjects: 40
Study: 34011557

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study: 35649167

Group type: EXPERIMENTAL
Intervention: Dextromethorphan-bupropion (45 mg-105 mg tablet), orally (once daily for days 1-3, twice daily thereafter) for 6 weeks
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo, orally (once daily for days 1-3, twice daily thereafter) for 6 weeks
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Dextromethorphan-bupropion
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 34500216

Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate photodynamic therapy (MAL‐PDT) with two treatments
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Methyl aminolevulinate photodynamic therapy (MAL‐PDT) with four treatments
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo vehicle (control)
Number of subjects: 33
Study: 34524919

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 34988703

Group type: EXPERIMENTAL
Intervention: Primary/interval debulking surgeries with classical chemotherapy (adjuvant/neoadjuvant) of intravenous tri‐weekly doses of paclitaxel + carboplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Common toxicities (anemia, constipation, weight loss)
Number of subjects: 0
Study: 33530190

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sling treatment
Number of subjects: 0
Study: 35102424

Group type: EXPERIMENTAL
Intervention: 7.5 mg THC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 15 mg THC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: THC (both doses)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study: 34496848

Group type: EXPERIMENTAL
Intervention: Boosted darunavir plus dolutegravir (2DR)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Continuous boosted darunavir plus 2 nucleoside/nucleotide reverse‐transcriptase inhibitors (3DR)
Number of subjects: 263
Study: 32084245

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard taping (ST)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No taping (NT)
Number of subjects: 45
Study: 36128262

Group type: EXPERIMENTAL
Intervention: 5 mg Olanzapine
Number of subjects: 210

Group type: COMPARATOR
Intervention: Aprepitant
Number of subjects: 210
Study: 32557475

Group type: EXPERIMENTAL
Intervention: Nurse-led educational intervention by telephone within 48 hours before colonoscopy
Number of subjects: 657

Group type: COMPARATOR
Intervention: Standard bowel preparation protocol (Control)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Nurse-led educational intervention by telephone (Per-protocol analysis)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Standard bowel preparation protocol (Control, Per-protocol analysis)
Number of subjects: 657
Study: 36223406

Group type: EXPERIMENTAL
Intervention: 8 wk pulmonary rehabilitation (PR) + routine medication
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine medication (Control Group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EOS ≥ 200 cells/μL group (within RG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EOS < 200 cells/μL group (within RG)
Number of subjects: 50
Study: 33494027

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intrauterine insemination (UG-IUI)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Classical intrauterine insemination (C-IUI)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intrauterine insemination (UG-IUI) for multigravida women
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intrauterine insemination (UG-IUI) for nulligravida women
Number of subjects: 320
Study: 36345569

Group type: EXPERIMENTAL
Intervention: Dapivirine Vaginal Ring (DVR)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 33340727

Group type: EXPERIMENTAL
Intervention: ESP-PCA
Number of subjects: 80

Group type: COMPARATOR
Intervention: PCA
Number of subjects: 80
Study: 35708823

Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 0
Study: 33827496

Group type: EXPERIMENTAL
Intervention: Early Intervention - Standard Care (EI-SC) group, 30-day EI program
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard Care - Early Intervention (SC-EI) group, standard care followed by EI in open phase
Number of subjects: 73

Group type: COMPARATOR
Intervention: Reference group (retrospective)
Number of subjects: 73
Study: 32792403

Group type: EXPERIMENTAL
Intervention: All-Christian soccer team
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed team with Muslims
Number of subjects: 0
Study: 34049519

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg daily from 2 days pre-operation to 14 days post-surgery
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 32259902

Group type: EXPERIMENTAL
Intervention: Guideline-directed medical therapy (GDMT) for systolic heart failure, including renin angiotensin aldosterone system inhibitors, initiated at low doses with close monitoring of kidney function.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrafiltration for volume status management.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient education and engagement regarding sodium and fluid restriction.
Number of subjects: 0
Study: 37428421

Group type: EXPERIMENTAL
Intervention: Alcohol Intake Feedback (Alc)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Alcohol Intake plus Cognitive Feedback (AlcCog)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Control
Number of subjects: 436
Study: 33894037

Group type: EXPERIMENTAL
Intervention: Genetically determined 1-unit higher log-transformed serum MMP-8 concentration
Number of subjects: 6049
Study: 32956804

Group type: EXPERIMENTAL
Intervention: Orthopedic RCTs
Number of subjects: 68

Group type: COMPARATOR
Intervention: Non-orthopedic RCTs
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Orthopedic RCTs favoring non-operative management
Number of subjects: 68
Study: 35803945

Group type: EXPERIMENTAL
Intervention: Technology Supported BB intervention group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 32909316

Group type: EXPERIMENTAL
Intervention: Isoniazid for 28 weeks during pregnancy
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 847

Group type: COMPARATOR
Intervention: Isoniazid
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Isoniazid and Efavirenz
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: NAT2 and CYP2B6 genotypes
Number of subjects: 847
Study: 33484485

Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA) followed by drug therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (drug therapy only)
Number of subjects: 27
Study: 32519221

Group type: EXPERIMENTAL
Intervention: Additional adhesive patches (RockaDex, New Zealand)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard adhesive (control)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Adhesive patch use
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Adhesive patch non-use
Number of subjects: 34
Study: 35065080

Group type: EXPERIMENTAL
Intervention: C12 + TRP
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: C12
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TRP
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 12
Study: 33030742

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (10 µg/day)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Vitamin D insufficiency
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: First-trimester vitamin D insufficiency
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 225
Study: 32600295

Group type: EXPERIMENTAL
Intervention: Immediately sequential bilateral cataract surgery (ISBCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed sequential bilateral cataract surgery (DSBCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ISBCS
Number of subjects: 0
Study: 36235746

Group type: EXPERIMENTAL
Intervention: 15 mg/kg D-Pinitol (n = 10)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 5 mg/kg D-Pinitol (n = 6)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1600 mg D-Pinitol from carob pods-derived syrup (n = 9)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: D-Pinitol (various doses)
Number of subjects: 35
Study: 32668455

Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Dolutegravir/Emtricitabine/Tenofovir Alafenamide (DTG + F/TAF)
Number of subjects: 567
Study: 32998938

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study: 35175380

Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 1133

Group type: COMPARATOR
Intervention: FFRCT
Number of subjects: 1133
Study: 35987552

Group type: EXPERIMENTAL
Intervention: Single-session online cognitive bias modification (CBM-IA) targeting interpretation bias and attribution style.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control condition (not specified).
Number of subjects: 45
Study: 32430879

Group type: EXPERIMENTAL
Intervention: SNAPPS
Number of subjects: 60

Group type: COMPARATOR
Intervention: OMP
Number of subjects: 60
Study: 33454705

Group type: EXPERIMENTAL
Intervention: Simulation-based training
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Training on healthy volunteer
Number of subjects: 66

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 66
Study: 35074319

Group type: EXPERIMENTAL
Intervention: Acupressure (n=52)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control (n=60)
Number of subjects: 112
Study: 33960064

Group type: EXPERIMENTAL
Intervention: Higher income (adjusted odds ratio (AOR) = 0.299)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Being physically active
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Physical disability (AOR = 3.03)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: High level of loneliness (AOR = 41.76)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Daily or occasional physical activity (AOR = 0.35; AOR = 0.50)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Digestive symptoms (AOR = 1.98)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Poor nutritional status (AOR = 1.99)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Strong feelings of loneliness (AOR = 10.86)
Number of subjects: 823
Study: 35368996

Group type: EXPERIMENTAL
Intervention: Be a Mom (self-guided web-based intervention)
Number of subjects: 800
Study: 34035052

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32826199

Group type: EXPERIMENTAL
Intervention: Virtual dodgeball game (Dodgeality)
Number of subjects: 0
Study: 37288499

Group type: EXPERIMENTAL
Intervention: Active photobiomodulation (PBM) therapy, 808 nm, 15 min, 16.5 J/cm2, self-applied at home for 3 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham photobiomodulation therapy, self-applied at home for 3 months
Number of subjects: 50
Study: 33705182

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 34486528

Group type: EXPERIMENTAL
Intervention: Exercise plus nutrient-dense weight maintenance diet
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Exercise plus weight loss by moderate caloric restriction
Number of subjects: 134
Study: 35861931

Group type: EXPERIMENTAL
Intervention: Culturally adapted version for Mexico (Mantente REAL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Original intervention from the USA (keepin' it REAL) translated into Spanish
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control condition (treatment as usual)
Number of subjects: 36
Study: 35822251

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery (HALS)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Laparoscopic-assisted surgery (LAS)
Number of subjects: 124
Study: 34272322

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 (6.0 GBq per cycle)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 (7.4 GBq per cycle)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Overall (177Lu-PSMA-617)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617
Number of subjects: 64
Study: 34859632

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 1361

Group type: COMPARATOR
Intervention: Non-prophylactic antibiotics
Number of subjects: 1361
Study: 32507149

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) for 10 minutes at 35 Hz and 2 mm amplitude
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (CG) remained on the platform for 10 minutes without vibratory stimulus
Number of subjects: 21
Study: 36399038

Group type: EXPERIMENTAL
Intervention: Photon-counting CT (PCCT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Standard energy-integrating detector (EID) CT
Number of subjects: 7
Study: 33789311

Group type: EXPERIMENTAL
Intervention: Pycnogenol® (2 × 50 mg/day for a total of 12 weeks)
Number of subjects: 76
Study: 32325914

Group type: EXPERIMENTAL
Intervention: ANS-LD (15 mg.kg−1.bw−1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ANS-HD (30 mg.kg−1.bw−1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 10
Study: 33788006

Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Circuit-based exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 60
Study: 32958537

Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 33121341

Group type: EXPERIMENTAL
Intervention: Incremental theory of personality intervention
Number of subjects: 535

Group type: COMPARATOR
Intervention: Alternative educational control condition
Number of subjects: 535
Study: 32803412

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) group (n = 143) aiming to decrease energy intake by 25%
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) group (n = 143)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Ad libitum (AL) group (n = 75)
Number of subjects: 218
Study: 34863330

Group type: EXPERIMENTAL
Intervention: Oral lyophilised FMT for 8 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo capsules for 8 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Continuation of FMT for 48 weeks (for responders)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Withdrawal of FMT for 48 weeks (for responders)
Number of subjects: 35
Study: 36378093

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises (PREs) performed once a day for 4 weeks in addition to standard treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 44
Study: 33775464

Group type: EXPERIMENTAL
Intervention: Question Prompt List (QPL) with 35 hand-specific questions
Number of subjects: 126

Group type: COMPARATOR
Intervention: AskShareKnow group with 3 generic questions
Number of subjects: 126